External Validation of the Benefit of Adjuvant Radiotherapy for Pathologic N1M0 Prostate Cancer

被引：8
|
作者：
Rusthoven, Chad G. [1 ]
Carlson, Julie A. [1 ]
Kavanagh, Brian D. [1 ]
机构：
[1] Univ Colorado, Sch Med, Aurora, CO USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 17期
关键词：
IMPACT;
D O I：
10.1200/JCO.2015.60.9404
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1987 / 1988
页数：2
相关论文
共 50 条
  • [1] The Horse is at the Stable Door: Management of N1M0 Prostate Cancer
    Thiruthaneeswaran, N.
    Hayden, A. J.
    Choudhury, A.
    [J]. CLINICAL ONCOLOGY, 2020, 32 (03) : 199 - 208
  • [2] PROSTATE CANCER pT3N0M0 prostate cancer: a plea for adjuvant radiation
    Bolla, Michel
    Collette, Laurence
    [J]. NATURE REVIEWS UROLOGY, 2009, 6 (08) : 410 - 412
  • [3] Adjuvant radiotherapy in patients with pathologic stage C (pT3N0) adenocarcinoma of the prostate
    Petrovich, Z
    Lieskovsky, G
    Langholz, B
    Bochner, B
    Formenti, S
    Streeter, O
    Skinner, DG
    [J]. UROLOGY, 1999, 53 (06) : 1184 - 1193
  • [4] pT3N0M0 prostate cancer: a plea for adjuvant radiation
    Michel Bolla
    Laurence Collette
    [J]. Nature Reviews Urology, 2009, 6 : 410 - 412
  • [5] The Role of Postmastectomy Radiotherapy in Women With Pathologic T3N0M0 Breast Cancer
    Cassidy, Richard J.
    Liu, Yuan
    Kahn, Shannon T.
    Jegadeesh, Naresh K.
    Liu, Xi
    Subhedar, Preeti D.
    Arciero, Cletus A.
    Gillespie, Theresa W.
    Torres, Mylin A.
    [J]. CANCER, 2017, 123 (15) : 2829 - 2839
  • [6] Development and External Validation of a Nomogram to Predict the Benefit of Regional Node Irradiation in Patients with pT1-2N1M0 Breast Cancer
    Sun, G.
    Wen, G.
    Zhang, Y. J.
    Tang, Y.
    Jing, H.
    Zhao, X.
    Chen, S.
    Jin, J.
    Song, Y.
    Liu, Y.
    Fang, H.
    Tang, Y.
    Qi, S.
    Li, N.
    Chen, B.
    Lu, N.
    Li, Y.
    Wang, S.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E23 - E24
  • [7] Radical Prostatectomy versus External Beam Radiotherapy for cT1-4N0M0 Prostate Cancer: Comparison of Patient Outcomes Including Mortality
    Taguchi, Satoru
    Fukuhara, Hiroshi
    Shiraishi, Kenshiro
    Nakagawa, Keiichi
    Morikawa, Teppei
    Kakutani, Shigenori
    Takeshima, Yuta
    Miyazaki, Hideyo
    Fujimura, Tetsuya
    Nakagawa, Tohru
    Kume, Haruki
    Homma, Yukio
    [J]. PLOS ONE, 2015, 10 (10):
  • [8] Lymph Node-Positive (N1M0) Prostate Cancer: An Analysis of Prognostic and Predictive Factors for Men Treated With and Without Definitive External Beam Radiation Therapy in the United States Population
    Rusthoven, C. G.
    Jackson, M. W.
    Amini, A.
    Raben, D.
    Kavanagh, B. D.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S14 - S14
  • [9] Comparison of surgery alone with surgery and adjuvant radiotherapy for pT3N0 prostate cancer
    Petrovich, Z
    Lieskovsky, G
    Stein, JP
    Huberman, M
    Skinner, DG
    [J]. BJU INTERNATIONAL, 2002, 89 (06) : 604 - 611
  • [10] Who can benefit from postmastectomy radiotherapy among HR+/HER2-T1-2 N1M0 breast cancer patients? An explainable machine learning mortality prediction based approach
    Jin, Long
    Zhao, Qifan
    Fu, Shenbo
    Zhang, Yuan
    Wu, Shuhan
    Li, Xiao
    Cao, Fei
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2024, 15
12345